Metraipolis › archive › dc_1db6fcb66b2f
Potential repurposing of lapatinib and pazopanib as neuroprotective agents in a rat model of Huntington's disease — Europe PMC PMID:40928618
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40928618
- DOI
- 10.1007/s10787-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T00:59:08.865Z
- SHA-256 of the archived text
413c8aca58ca1fb08184d537b549361fdfa25214e66711f030352ec231814d82- Stable URL of this page
https://metraipolis.com/documento/dc_1db6fcb66b2f
How to cite
Potential repurposing of lapatinib and pazopanib as neuroprotective agents in a rat model of Huntington's disease — Europe PMC PMID:40928618 — Europe PMC (en), https://europepmc.org/article/MED/40928618 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1db6fcb66b2f (Metraipolis archive dc_1db6fcb66b2f, sha256 413c8aca58ca1fb08184d537b549361fdfa25214e66711f030352ec231814d82)
BibTeX
@misc{dc1db6fcb66b2f,
title = {Potential repurposing of lapatinib and pazopanib as neuroprotective agents in a rat model of Huntington's disease — Europe PMC PMID:40928618},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40928618},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1db6fcb66b2f; sha256 413c8aca58ca1fb08184d537b549361fdfa25214e66711f030352ec231814d82},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40928618. Agents can read the archived copy with the MCP tool read_document.